2m 2m 2m 2m 2m 2m 2m
ATRIUM THERAP (RNA)
NASDAQ
$13.83+$1.61 (+13.14%)
Price as of Jul 14, 2026 4:20 AM EDT- $213.1MMarket Cap
- -63.60%1-Year Change
- BiotechnologyIndustry
ATRIUM THERAP (RNA)
$13.83+$1.61 (+13.14%)
RNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.22 | ||
Change | -$0.24 (-1.93%) | ||
Open | $12.40 | ||
High | $12.59 | ||
Low | $12.21 | ||
Previous Close | $12.46 | ||
Volume | 178,870 | ||
30-Day Average Volume | 261,356 | ||
1-Week Change | -6.07% | ||
1-Month Change | -1.21% | ||
1-Year Change | -63.60% | ||
3-Year Change | 10.29% | ||
5-Year Change | -48.81% | ||
Fundamentals | |||
Shares Outstanding | 17.1M | ||
Total Assets | $292.4M | ||
Market Cap | $213.1M | ||
Enterprise Value | -$54.7M | ||
Period: QTR TTM FY | |||
Revenue | $19.6M | ||
Net Income | -$16.6M | ||
Free Cash Flow | -$33.2M | ||
EBIT | -$16.6M | ||
EBITDA | -$16.5M | ||
Net Working Capital | N/A | ||
EPS | -$0.97 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -3 | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | N/A | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||